Health and Wellness
HIMSS22 Europe
Bringing together leaders from the supply side and the demand side of hospital digitalisation could be the key to a smoother transformation journey, as attendees at HIMSS22 Europe will find out.
They will provide the first access to an AI-enabled minimal residual disease test in India.
The tech giant also announced a new atrial fibrillation history feature and sleep stage tracking.
Also: Drug discovery platform Insilico Medicine raises $60 million, Women's virtual care startup Visana Health brings in $2.6 million and digital reproductive care clinic Choix scoops up $1 million.
If patients reported severe or worsening symptoms, their care teams were alerted.
Also, Standigm has partnered with Merck Korea for AI drug discovery research.
Also: Autism-focused SpectrumAi and cancer clinical trial platform Massive Bio both scooped up $9 million.
Researchers found therapists with a higher percentage of clients from lower socioeconomic status groups, patients on Medicaid and families were less likely to keep using telehealth after the pandemic.
Also: Mental health chatbot Woebot Health brings on Moses Ike as the company's first chief financial officer, and digital neurotherapeutic maker MindMaze announces a slew of new leadership hires.
The AI platform can predict a person's risk of having a stroke or a heart attack in the next five years.